| NCT ID | NCT07033117 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Indiana University |
| Condition | End Stage Renal Disease (ESRD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 14,000 participants |
| Start Date | 2025-10-27 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 14,000 participants in total. It began in 2025-10-27 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overarching goal of the proposed study is to determine whether the addition of structural interventions at the health system level targeting upstream barriers in the transplant process will improve access to transplant evaluation start.
Eligibility Criteria
Inclusion Criteria: * Five large transplant centers (Emory Transplant Center and Piedmont Transplant Center in Atlanta, GA; Medical University of SC; Duke University in Durham, NC; and Indiana University in Indianapolis, IN) \~800 referring dialysis center referring to these transplant centers Exclusion Criteria: * Individuals referred, initiating evaluation, and waitlisted at non-participating start centers
Frequently Asked Questions
Who can join the NCT07033117 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying End Stage Renal Disease (ESRD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07033117 currently recruiting?
Yes, NCT07033117 is actively recruiting participants. Visit ClinicalTrials.gov or contact Indiana University to inquire about joining.
Where is the NCT07033117 trial being conducted?
This trial is being conducted at Atlanta, United States, Atlanta, United States, Indianapolis, United States, Durham, United States and 1 additional location.
Who is sponsoring the NCT07033117 clinical trial?
NCT07033117 is sponsored by Indiana University. The trial plans to enroll 14,000 participants.